DrugPatentWatch Database Preview
Investigational Drug Information for Sulodexide
Email this page to a colleague
What is the development status for investigational drug Sulodexide?
Sulodexide is an investigational drug.
There have been 18 clinical trials for Sulodexide.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2005.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Arterial Occlusive Diseases. The leading clinical trial sponsors are Collaborative Study Group (CSG), Keryx Biopharmaceuticals, and Alfasigma S.p.A.
Summary for Sulodexide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 761 |
| WIPO Patent Applications | 412 |
| Japanese Patent Applications | 88 |
| Clinical Trial Progress | Phase 3 (2005-08-01) |
| Vendors | 11 |
Recent Clinical Trials for Sulodexide
| Title | Sponsor | Phase |
|---|---|---|
| Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities | Alfasigma S.p.A. | Phase 3 |
| Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities | Value Outcomes Ltd. | Phase 3 |
| Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) | Arianna Anticoagulazione Foundation | Phase 3 |
Clinical Trial Summary for Sulodexide
Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide
US Patents for Sulodexide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
